REQUEST A DEMO
Total
USD $0.00
Search more companies

Lumex Pharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lumex Pharma S.A.S. Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Lumex Pharma S.A.S. is an enterprise located in Colombia, with the main office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on July 31, 2020. 8 (2026) employees currently work for Lumex Pharma S.A.S.. The latest financial highlights indicate a net sales revenue increase of 1209.41% in 2025. There was a total growth of 197.33% in Lumex Pharma S.A.S.’s total assets over the same period. The net profit margin of Lumex Pharma S.A.S. increased by 3.66% in 2025.

Headquarters
Avenida Carrera 19 118 30 Oficina 511
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Lumex Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Lumex Pharma S.A.S. report to view the information.
Financial Auditors:
Purchase the Lumex Pharma S.A.S. report to view the information.
Incorporation Date:
July 31, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Lumex Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
1209.41%
Total Operating Revenue
1209.41%
Operating Profit
203.61%
Net Profit/Loss for the Period
2585.41%
Total Assets
197.33%
Total Equity
221.95%
Operating Profit Margin
-55.39%
Net Profit Margin
3.66%
Return on Equity (ROE)
48.96%
Quick Ratio
0.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?